financetom
Business
financetom
/
Business
/
Tidewater Midstream Trims Q2 Net Loss
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tidewater Midstream Trims Q2 Net Loss
Aug 15, 2024 4:49 AM

07:18 AM EDT, 08/15/2024 (MT Newswires) -- Tidewater Midstream and Infrastructure ( TWMIF ) said earlier Thursday that it narrowed its attributable net loss in the second quarter.

The company reported an attributable net loss of $4.7 million, or $0.01 per share, trimming the previous attributable net loss of $6.4 million, or $0.02 per share.

Tidewater attributed the improvement to higher operating income, offset in part by unfavorable changes in the fair value of derivative contracts, and the absence of a deferred income tax recovery.

Adjusted EBITDA inched up to $45.3 million from $44.0 million.

Tidewater cut its 2024 adjusted EBITDA guidance to a range of $130 million to $150 million from $150 million to $170 million, citing uncertainty surrounding British Columbia's low-carbon fuel standard credit market.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Figs Stock Jumps On Takeover Offer From Private-Equity Firm
Figs Stock Jumps On Takeover Offer From Private-Equity Firm
Dec 11, 2024
FIGS Inc ( FIGS ) shares are trading higher Wednesday following reports suggesting the company received a takeover offer from Story3 Capital Partners. What To Know: According to a Wall Street Journal report, private-equity firm Story3 Capital Partners sent a takeover offer to medical-apparel maker Figs, valuing the company at more than $1 billion. The private-equity firm reportedly offered $6...
REUTERS NEXT-US bank executives expect Trump to ease rules, fuel growth
REUTERS NEXT-US bank executives expect Trump to ease rules, fuel growth
Dec 11, 2024
NEW YORK (Reuters) - President-elect Donald Trump is expected to adopt pro-growth policies that ease U.S. banking and credit card regulations, while spurring deals, industry executives said on a panel at the Reuters NEXT conference in New York on Wednesday. I hope the new administration will use this as a point to do a reset, Barclays U.S. consumer Bank CEO Denny Nealon...
Enlivex Therapeutics Gets Approval for Phase 1 Trial of Allocetra to Treat Osteoarthritis
Enlivex Therapeutics Gets Approval for Phase 1 Trial of Allocetra to Treat Osteoarthritis
Dec 11, 2024
11:02 AM EST, 12/11/2024 (MT Newswires) -- Enlivex Therapeutics ( ENLV ) said Wednesday it received authorization from the Israeli Ministry of Health to start a phase 1 clinical trial of Allocetra after injection into the temporomandibular joint in osteoarthritis patients. The company intends to evaluate the frequency and severity of adverse events, including serious adverse events, as the primary...
Pharming Reports Positive Phase III Data on Leniolisib in Children With Rare Primary Immunodeficiency; Shares Rise
Pharming Reports Positive Phase III Data on Leniolisib in Children With Rare Primary Immunodeficiency; Shares Rise
Dec 11, 2024
11:00 AM EST, 12/11/2024 (MT Newswires) -- Pharming Group ( PHAR ) reported Wednesday positive phase III data for its investigational drug leniolisib in children aged between four and 11 years with activated phosphoinositide 3-kinase delta syndrome, a rare primary immunodeficiency. The biopharmaceutical company said the data was consistent with improvements seen in a previously reported randomized controlled trial in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved